Person

Christian Hartinger

This person is no longer with EPFL

Related publications (50)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Christian Hartinger

Graph Chatbot

Chat with Graph Search

Understanding the interactions of diruthenium anticancer agents with amino acids

The development of RAPTA compounds for the treatment of tumors

Target profiling of an antimetastatic RAPTA agent by chemical proteomics: relevance to the mode of action

Protein ruthenation and DNA alkylation: chlorambucil-functionalized RAPTA complexes and their anticancer activity

Opening the lid on piano-stool complexes: An account of ruthenium(II)-arene complexes with medicinal applications

Application of mass spectrometric techniques to delineate the modes-of-action of anticancer metallodrugs

A new target for gold(I) compounds: glutathione-S.transferase inhibition by auranofin

Synthesis of [Ru-II(eta(6)-p-cymene)(PPh3)(L)Cl]PF6 complexes with carbohydrate-derived phosphites, imidazole or indazole co-ligands

Fragmentation methods on the balance: unambiguous top–down mass spectrometric characterization of oxaliplatin–ubiquitin binding sites

Anthracene-Tethered Ruthenium(II) Arene Complexes as Tools To Visualize the Cellular Localization of Putative Organometallic Anticancer Compounds